title: [Cesarean section in a myasthenia gravis patient].
authors.forename: E
authors.initials: E
authors.lastname: Facorro
authors.forename: A
authors.initials: A
authors.lastname: Vaquerizo
authors.forename: A
authors.initials: A
authors.lastname: Bondía
authors.forename: J L
authors.initials: JL
authors.lastname: Sola
authors.forename: J
authors.initials: J
authors.lastname: Cuartero
mesh_terms: D000328:Adult; D000767:Anesthesia, Epidural / Q000379:methods*; D000773:Anesthesia, Obstetrical / Q000379:methods*; D000779:Anesthetics, Local; D002045:Bupivacaine; D002585:Cesarean Section; D000075202:Contraindications; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009157:Myasthenia Gravis / Q000151:congenital / Q000188:drug therapy / Q000276:immunology; D009466:Neuromuscular Blocking Agents; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000276:immunology; D011729:Pyridostigmine Bromide / Q000627:therapeutic use
chemical_list: D000779:Anesthetics, Local; D009466:Neuromuscular Blocking Agents; D011729:Pyridostigmine Bromide; D002045:Bupivacaine